Publication list - Publika - Scientific publications from Oslo University Hospital

Publications by Tom Bergan

388 publications found

Original articles

Bergan T, Dowdall M, Selnaes OG (2007)
On the occurrence of radioactive fallout over Norway as a result of the Windscale accident, October 1957
J Environ Radioact, 99 (1), 50-61
DOI 10.1016/j.jenvrad.2007.06.011, PubMed 17764791

Bergan T (2001)
Antibiotic usage in Nordic countries
Int J Antimicrob Agents, 18 (3), 279-82
DOI 10.1016/s0924-8579(01)00382-x, PubMed 11673043

Bergan T, Klaveness J, Aasen AJ (2001)
Chelating agents
Chemotherapy, 47 (1), 10-4
DOI 10.1159/000048495, PubMed 11125227

Davis JL, Heginbottom JA, Annan AP, Daniels RS, Berdal BP, Bergan T, Duncan KE, Lewin PK, Oxford JS, Roberts N, Skehel JJ, Smith CR (2000)
Ground penetrating radar surveys to locate 1918 Spanish flu victims in permafrost
J Forensic Sci, 45 (1), 68-76
DOI 10.1520/JFS14642J, PubMed 10641921

Stray-Pedersen B, Bergan T, Hafstad A, Normann E, Grøgaard J, Vangdal M (1999)
Vaginal disinfection with chlorhexidine during childbirth
Int J Antimicrob Agents, 12 (3), 245-51
DOI 10.1016/s0924-8579(99)00068-0, PubMed 10461843

Gautun HS, Bergan T, Carlsen PH (1999)
Preparation and antimicrobial studies of acyclic sulfamates
Acta Chem Scand (Cph), 53 (6), 446-52
DOI 10.3891/acta.chem.scand.53-0446, PubMed 10377951

Dahlgren A, Gløgård C, Gammelsaether M, Aasen AJ, Klaveness J, Berdal BP, Bergan T (1999)
Organobismuth compounds: activity against Helicobacter pylori
Scand J Gastroenterol, 34 (2), 135-7
DOI 10.1080/00365529950172970, PubMed 10192189

Jenks PJ, Akalin E, Bergan T, Dornbusch K, Howard AJ, Hryniewicz W, Jones JR, King A, McLaughlin JC, Ozkuyumcu C, Percival A, Phillips I, Reeves DS, Spencer R, Vatopoulos AC, Warren R, Williams JD (1998)
Susceptibility testing of Klebsiella spp.--an international collaborative study in quality assessment
J Antimicrob Chemother, 42 (1), 29-48
DOI 10.1093/jac/42.1.29, PubMed 9700526

Bergan T, Gaustad P, Høiby EA, Berdal BP, Furuberg G, Baann J, Tønjum T (1998)
Antibiotic resistance of pneumococci in Norway
Int J Antimicrob Agents, 10 (1), 77-81
DOI 10.1016/s0924-8579(98)00018-1, PubMed 9624547

Bergan T, Bruun JN, Digranes A, Lingaas E, Melby KK, Sander J (1997)
Susceptibility testing of bacteria and fungi. Report from "the Norwegian Working Group on Antibiotics"
Scand J Infect Dis Suppl, 103, 1-36
PubMed 9253777

Yeo SF, Akalin E, Arikan S, Auckenthaler R, Bergan T, Dornbusch K, Howard AJ, Hryniewicz W, Jones RN, Koupari G, Legakis NJ, McLaughlin J, Ozkuyumcu C, Percival A, Phillips I, Reeves D, Spencer R, Warren RE, Williams JD (1996)
Susceptibility testing of Haemophilus influenzae--an international collaborative study in quality assessment
J Antimicrob Chemother, 38 (3), 363-86
DOI 10.1093/jac/38.3.363, PubMed 8889713

Sandal GM, Vaernes R, Bergan T, Warncke M, Ursin H (1996)
Psychological reactions during polar expeditions and isolation in hyperbaric chambers
Aviat Space Environ Med, 67 (3), 227-34
PubMed 8775400

Tønjum T, Klintz L, Bergan T, Baann J, Furuberg G, Cristea M, Petrini B, Hoffner S (1996)
Direct detection of Mycobacterium tuberculosis in respiratory samples from patients in Scandinavia by polymerase chain reaction
Clin Microbiol Infect, 2 (2), 127-131
DOI 10.1111/j.1469-0691.1996.tb00218.x, PubMed 11866830

BERGAN T (1995)
Pharmacokinetics of newer macrolides
INFEC DIS T, 18, 51-60

URSIN H, BERGAN T, SANDAL G (1995)
A biobehavioral monitoring system for space travelers
BIOBEHAVIORAL SELF-REGULATION: EASTERN AND WESTERN PERSPECTIVES, 46-51

Nygaard K, Bergan T, Bjørneklett A, Høverstad T, Lassen J, Aase S (1994)
Topical metronidazole treatment in pouchitis
Scand J Gastroenterol, 29 (5), 462-7
DOI 10.3109/00365529409096839, PubMed 8036463

Phillips I, Acar J, Bergan T, Degener J, Schito GC (1994)
European Study Group on Antibiotic Breakpoints. Breakpoint determination: cefepime
Eur J Clin Microbiol Infect Dis, 13 (3), 282-3
DOI 10.1007/BF01974555, PubMed 8050448

Phillips I, Acar J, Baquero F, Bergan T, Degener J, Forsgren A, Schito GC, Wiedemann B (1994)
European Study Group on Antibiotic Breakpoints. Breakpoint determination: sparfloxacin
Eur J Clin Microbiol Infect Dis, 13 (3), 283-4
DOI 10.1007/BF01974556, PubMed 8050449

BERGAN T (1994)
PHARMACOKINETIC PROFILE OF BRODIMOPRIM - ORAL BIOAVAILABILITY AND PENETRATION IN INTERSTITIAL LIQUID
J. Chemother., 6 1, 118-120

Bergan T (1993)
Pharmacokinetic profile of brodimoprim: oral bioavailability and penetration into interstitial fluid
J Chemother, 5 (6), 488-9
DOI 10.1080/1120009X.1993.11741101, PubMed 8195842

Olsen H, Bergan T, Romslo I, Heier HE, Lundemo G, Pedersen JC (1993)
[Personnel crisis of Norwegian laboratory medicine]
Tidsskr Nor Laegeforen, 113 (18), 2304-5
PubMed 8362406

Vaernes RJ, Bergan T, Warncke M, Ursin H, Aakvaag A, Hockey R (1993)
European isolation and confinement study. Workload and stress: effects on psychosomatic and psychobiological reaction patterns
Adv Space Biol Med, 3, 95-120
PubMed 8166854

Bergan T, Thorsteinsson SB, Albini E (1993)
Pharmacokinetic profile of fosfomycin trometamol
Chemotherapy, 39 (5), 297-301
DOI 10.1159/000239140, PubMed 8370321

Vaernes RJ, Bergan T, Lindrup A, Hammerborg D, Warncke M (1993)
European isolation and confinement study. Mental performance
Adv Space Biol Med, 3, 121-37
PubMed 8124498

Bergan T, da Fonseca J (1993)
Antibacterial activity of cefcanel
Chemotherapy, 39 (2), 96-104
DOI 10.1159/000239109, PubMed 8458252

Bergan T, Michalsen H, Malmborg AS, Pedersen SS, Pressler T, Storrøsten OT, Strandvik B (1993)
Pharmacokinetic evaluation of imipenem combined with cilastatin in cystic fibrosis
Chemotherapy, 39 (6), 369-73
DOI 10.1159/000238979, PubMed 8222862

Bergan T, Sandal G, Warncke M, Ursin H, Vaernes RJ (1993)
European isolation and confinement study. Group functioning and communication
Adv Space Biol Med, 3, 59-80
PubMed 8124511

Charnock C, Bergan T (1992)
Multilocus enzyme electrophoresis of major O-antigen reference strains of Pseudomonas aeruginosa
Eur J Clin Microbiol Infect Dis, 11 (9), 810-6
DOI 10.1007/BF01960880, PubMed 1281769

Bergan T, Jørgensen NP, Olszewski W, Zhang Y (1992)
Azithromycin pharmacokinetics and penetration to lymph
Scand J Infect Dis Suppl, 83, 15-21
PubMed 1336891

BERGAN T, JORGENSEN NP, OLSZEWSKI W, ZHANG Y (1992)
AZITHROMYCIN PHARMACOKINETICS AND PENETRATION TO LYMPH
Scand. J. Infect. Dis. (83), 15-21

Kalager T, Andersen BM, Bergan T, Brubakk O, Bruun JN, Døskeland B, Hellum KB, Hopen G, von der Lippe E, Rahm V (1992)
Ciprofloxacin versus a tobramycin/cefuroxime combination in the treatment of serious systemic infections: a prospective, randomized and controlled study of efficacy and safety
Scand J Infect Dis, 24 (5), 637-46
DOI 10.3109/00365549209054651, PubMed 1465583

Phillips I, Acar J, Baquero F, Bergan T, Forsgren A, Wiedemann B (1991)
ESGAB breakpoint determination: clarithromycin
Eur J Clin Microbiol Infect Dis, 10 (11), 993-4
DOI 10.1007/BF02005466, PubMed 1838979

URSIN H, BERGAN T, COLLET J, ENDRESEN IM, LUGG DJ, MAKI P, MATRE R, MOLVAER O, OLFF M, MULLER HK, PETTERSEN R, SANDAL GM, VAERNES R, WARNCKE M (1991)
PSYCHOBIOLOGICAL STUDIES OF INDIVIDUALS IN SMALL, ISOLATED GROUPS IN THE ANTARCTIC AND IN SPACE ANALOGS
Environ. Behav., 23 (6), 766-781
DOI 10.1177/0013916591236007

Phillips I, Acar J, Baquero F, Bergan T, Forsgren A, Wiedemann B (1991)
ESGAB breakpoint determination: temafloxacin
Eur J Clin Microbiol Infect Dis, 10 (11), 991-2
DOI 10.1007/BF02005465, PubMed 1665417

Bergan T, da Fonseca J (1991)
Comparative antibacterial activity of the penem ALP 201
Chemotherapy, 37 (6), 413-9
DOI 10.1159/000238888, PubMed 1760940

Rohwedder R, Bergan T, Caruso E, Thorsteinsson SB, Della Torre H, Scholl H (1991)
Penetration of ciprofloxacin and metabolites into human lung, bronchial and pleural tissue after 250 and 500 mg oral ciprofloxacin
Chemotherapy, 37 (4), 229-38
DOI 10.1159/000238860, PubMed 1790720

Bergan T, da Fonseca J (1991)
Efficacy of cefcanel on staphylocci
Chemotherapy, 37 (1), 43-9
DOI 10.1159/000238831, PubMed 2013241

Stray-Pedersen B, Biørnstad J, Dahl M, Bergan T, Aanestad G, Kristiansen L, Hansen K (1991)
Induced abortion: microbiological screening and medical complications
Infection, 19 (5), 305-8
DOI 10.1007/BF01645352, PubMed 1800368

Bergan T (1990)
Requirements for the documentation of pharmacokinetic properties of antimicrobial agents
Eur J Clin Microbiol Infect Dis, 9 (7), 506-9
DOI 10.1007/BF01964292, PubMed 2226481

Stray-Pdersen B, Blakstad M, Bergan T (1990)
Bacteriuria in the puerperium. Risk factors, screening procedures, and treatment programs
Am J Obstet Gynecol, 162 (3), 792-7
DOI 10.1016/0002-9378(90)91012-2, PubMed 2316591

Bergan T (1990)
Degree of absorption, pharmacokinetics of fosfomycin trometamol and duration of urinary antibacterial activity
Infection, 18 Suppl 2, S65-9
DOI 10.1007/BF01643430, PubMed 2286464

Bergan T (1990)
Extravascular penetration of ciprofloxacin. A review
Diagn Microbiol Infect Dis, 13 (2), 103-14
DOI 10.1016/0732-8893(90)90093-b, PubMed 2196148

Rohwedder RW, Bergan T, Thorsteinsson SB, Scholl H (1990)
Transintestinal elimination of ciprofloxacin
Diagn Microbiol Infect Dis, 13 (2), 127-33
DOI 10.1016/0732-8893(90)90095-d, PubMed 2369809

Thorsteinsson SB, Bergan T, Rahm V, Rohwedder RW (1990)
Safety of intravenous ciprofloxacin in healthy volunteers after multiple dosing. A review
Diagn Microbiol Infect Dis, 13 (2), 191-3
DOI 10.1016/0732-8893(90)90108-8, PubMed 2196156

BERGAN T (1990)
PHARMACOKINETIC PARAMETERS AND CHARACTERISTICS RELEVANT TO ANTIMICROBIAL SURGICAL PROPHYLAXIS
Scand. J. Infect. Dis. (70), 31-35

Rohwedder R, Bergan T, Thorsteinsson SB, Scholl H (1990)
Transintestinal elimination of ciprofloxacin
Chemotherapy, 36 (2), 77-84
DOI 10.1159/000238751, PubMed 2311444

Bergan T (1990)
Pharmacokinetic comparison between fosfomycin and other phosphonic acid derivatives
Chemotherapy, 36 Suppl 1, 10-8
DOI 10.1159/000238809, PubMed 2085981

Nord CE, Bergan T, Thorsteinsson SB (1989)
Impact of ticarcillin/clavulanate on the intestinal microflora
J Antimicrob Chemother, 24 Suppl B, 221-6
DOI 10.1093/jac/24.suppl_b.221, PubMed 2606816

Bergan T (1989)
Pharmacokinetics of ciprofloxacin with reference to other fluorinated quinolones
J Chemother, 1 (1), 10-7
DOI 10.1080/1120009x.1989.11738857, PubMed 2542469

THORSTEINSSON SB, RAHM V, BERGAN T (1989)
TOLERANCE OF INTRAVENOUS CIPROFLOXACIN
Scand. J. Infect. Dis. (60), 116-119

Bergan T (1989)
Susceptibility of clinical isolates to dactimicin and gentamicin
Drugs Exp Clin Res, 15 (3), 109-12
PubMed 2752907

Bergan T, Thorsteinsson SB, Rohwedder R, Scholl H (1989)
Elimination of ciprofloxacin and three major metabolites and consequences of reduced renal function
Chemotherapy, 35 (6), 393-405
DOI 10.1159/000238702, PubMed 2612228

Vaernes RJ, Bergan T, Warncke M (1988)
HPNS effects among 18 divers during compression to 360 msw on heliox
Undersea Biomed Res, 15 (4), 241-55
PubMed 3212842

Strandvik B, Malmborg AS, Bergan T, Michalsen H, Storrøsten OT, Wretlind B (1988)
Imipenem/cilastatin, an alternative treatment of pseudomonas infection in cystic fibrosis
J Antimicrob Chemother, 21 (4), 471-80
DOI 10.1093/jac/21.4.471, PubMed 3132441

Poh CL, Yap EH, Tay L, Bergan T (1988)
Plasmid profiles compared with serotyping and pyocin typing for epidemiological surveillance of Pseudomonas aeruginosa
J Med Microbiol, 25 (2), 109-14
DOI 10.1099/00222615-25-2-109, PubMed 3123694

Bergan T, Lolekha S, Cheong MK, Poh CL, Doencham S, Charoenpipop D (1988)
Effect of recent antibacterial agents against bacteria causing diarrhoea
Scand J Infect Dis Suppl, 56, 7-10
PubMed 3266900

Bergan T, Dalhoff A, Rohwedder R (1988)
Pharmacokinetics of ciprofloxacin
Infection, 16 Suppl 1, S3-13
DOI 10.1007/BF01650500, PubMed 3286512

BERGAN T, LOLEKHA S, CHEONG MK, POH CL, DOENCHAM S, CHAROENPIPOP D (1988)
EFFECT OF RECENT ANTIBACTERIAL AGENTS AGAINST BACTERIA CAUSING DIARRHEA
Scand. J. Infect. Dis. (56), 7-10

Thorsteinsson SB, Bergan T, Rohwedder R (1988)
Tolerance of intravenously administered ciprofloxacin
Chemotherapy, 34 (3), 256-60
DOI 10.1159/000238577, PubMed 3416662

Bergan T, Lolekha S, Cheong MK, Poh CL, Patancharoen S (1988)
Consequences of diarrhoeal disease on the pharmacokinetics of norfloxacin
Scand J Infect Dis Suppl, 56, 11-3
PubMed 3249925

BERGAN T, LOLEKHA S, CHEONG MK, POH CL, PATANCHAROEN S (1988)
CONSEQUENCES OF DIARRHEAL DISEASE ON THE PHARMACOKINETICS OF NORFLOXACIN
Scand. J. Infect. Dis. (56), 11-13

Fluge G, Digranes A, Michalsen H, Stiris T, Bergan T, Qvigstad EK (1987)
Ceftazidime treatment of chronic Pseudomonas infection in patients with cystic fibrosis
Eur J Respir Dis, 71 (4), 239-43
PubMed 3319661

Bergan T (1987)
Optimization of pharmacokinetic documentation for new antibacterial agents
Chemioterapia, 6 (2 Suppl), 240-2
PubMed 3509397

Bergan T, Thorsteinsson SB, Solberg R, Bjornskau L, Kolstad IM, Johnsen S (1987)
Pharmacokinetics of ciprofloxacin: intravenous and increasing oral doses
Am J Med, 82 (4A), 97-102
PubMed 3578334

Wells DE, Reeves MW, McKinney RM, Graves LM, Olsvik O, Bergan T, Feeley JC (1987)
Production and characterization of monoclonal antibodies to toxic shock syndrome toxin 1 and use of a monoclonal antibody in a rapid, one-step enzyme-linked immunosorbent assay for detection of picogram quantities of toxic shock syndrome toxin 1
J Clin Microbiol, 25 (3), 516-21
DOI 10.1128/jcm.25.3.516-521.1987, PubMed 3106406

Thorsteinsson SB, Bergan T, Johannesson G, Thorsteinsson HS, Rohwedder R (1987)
Tolerance of ciprofloxacin at injection site, systemic safety and effect on electroencephalogram
Chemotherapy, 33 (6), 448-51
DOI 10.1159/000238534, PubMed 3428012

Bergan T (1987)
Pharmacokinetic properties of the cephalosporins
Drugs, 34 Suppl 2, 89-104
DOI 10.2165/00003495-198700342-00008, PubMed 3319507

Edlund C, Bergan T, Josefsson K, Solberg R, Nord CE (1987)
Effect of norfloxacin on human oropharyngeal and colonic microflora and multiple-dose pharmacokinetics
Scand J Infect Dis, 19 (1), 113-21
DOI 10.3109/00365548709032386, PubMed 3563419

Michalsen H, Bergan T (1986)
Pharmacokinetics of azlocillin in children with and without cystic fibrosis treated for infectious diseases
Methods Find Exp Clin Pharmacol, 8 (12), 727-9
PubMed 3807473

Michalsen H, Bergan T, Solberg R (1986)
Pharmacokinetic evaluation of cefsulodin in children with and without cystic fibrosis treated for infectious diseases
Methods Find Exp Clin Pharmacol, 8 (11), 685-7
PubMed 3807469

Bergan T, Engeset A, Olszewski W, Ostby N, Solberg R (1986)
Extravascular penetration of highly protein-bound flucloxacillin
Antimicrob Agents Chemother, 30 (5), 729-32
DOI 10.1128/AAC.30.5.729, PubMed 3800349

Iveland H, Skaug K, Dahl M, Bergan T, Stray-Pedersen B, Anestad G, Gundersen T, Andersen GM (1986)
[Chlamydia trachomatis. Direct detection with an immunofluorescence test]
Tidsskr Nor Laegeforen, 106 (22), 1689-90, 1673
PubMed 3535161

Kalager T, Digranes A, Bergan T, Rolstad T (1986)
Ofloxacin: serum and skin blister fluid pharmacokinetics in the fasting and non-fasting state
J Antimicrob Chemother, 17 (6), 795-800
DOI 10.1093/jac/17.6.795, PubMed 3460984

Bergan T, Thorsteinsson SB, Kolstad IM, Johnsen S (1986)
Pharmacokinetics of ciprofloxacin after intravenous and increasing oral doses
Eur J Clin Microbiol, 5 (2), 187-92
DOI 10.1007/BF02013984, PubMed 2941278

Bergan T, Delin C, Johansen S, Kolstad IM, Nord CE, Thorsteinsson SB (1986)
Pharmacokinetics of ciprofloxacin and effect of repeated dosage on salivary and fecal microflora
Antimicrob Agents Chemother, 29 (2), 298-302
DOI 10.1128/AAC.29.2.298, PubMed 2940965

Bergan T, Thorsteinsson SB (1986)
Pharmacokinetics of metronidazole and its metabolites in reduced renal function
Chemotherapy, 32 (4), 305-18
DOI 10.1159/000238429, PubMed 3731917

Thorsteinsson SB, Bergan T, Oddsdottir S, Rohwedder R, Holm R (1986)
Crystalluria and ciprofloxacin, influence of urinary pH and hydration
Chemotherapy, 32 (5), 408-17
DOI 10.1159/000238444, PubMed 3019613

Bergan T, Bruun JN, Ostby N, Bredesen JE, Lunde PK (1986)
Human pharmacokinetics and skin blister levels of sulfonamides and dihydrofolate reductase inhibitors
Chemotherapy, 32 (4), 319-28
DOI 10.1159/000238430, PubMed 3731918

Nord CE, Bergan T, Aase S (1986)
Impact of azlocillin on the colon microflora
Scand J Infect Dis, 18 (2), 163-6
DOI 10.3109/00365548609032323, PubMed 3704564

Bergan T, Olszewski W, Engeset A (1986)
Penetration to peripheral human lymph of clavulanic acid and ticarcillin
J Antimicrob Chemother, 17 (1), 97-103
DOI 10.1093/jac/17.1.97, PubMed 3949640

Bergan T, Allgulander S, Fellner H (1986)
Pharmacokinetics of co-trimazine (sulphadiazine plus trimethoprim) in geriatric patients
Chemotherapy, 32 (6), 478-85
DOI 10.1159/000238456, PubMed 3802953

Bergan T, Engeset A, Olszewski W (1986)
Pharmacokinetics of oral co-trimazine and the penetration of its components sulfadiazine and trimethoprim into peripheral human lymph
Chemotherapy, 32 (3), 209-21
DOI 10.1159/000238418, PubMed 3709270

Bergan T, Solhaug JH, Søreide O, Leinebø O (1985)
Comparative pharmacokinetics of metronidazole and tinidazole and their tissue penetration
Scand J Gastroenterol, 20 (8), 945-50
DOI 10.3109/00365528509088853, PubMed 4081633

Roland M, Bergan T, Bjerkeset T, Erichsen H, Hoel R, Johansen S, Liavåg I, Reinertsen S, Rosseland A, Teigan T (1985)
Prophylactic regimens in colorectal surgery: comparisons between metronidazole used alone or with ampicillin for one or three days
World J Surg, 9 (4), 626-32
DOI 10.1007/BF01656069, PubMed 4036156

Olsvik O, Solberg R, Bergan T (1985)
Characterization of enterotoxigenic Escherichia coli. Serotypes, enterotoxins, adhesion fimbriae, and the presence of plasmids
Acta Pathol Microbiol Immunol Scand B, 93 (4), 255-62
PubMed 2413710

Bergan T (1985)
[Uncertain conclusions about adverse effects. Metronidazole and tinidazole]
Tidsskr Nor Laegeforen, 105 (7), 516-7
PubMed 3992542

Kapperud G, Skarpeid HJ, Solberg R, Bergan T (1985)
Outer membrane proteins and plasmids in different Yersinia enterocolitica serogroups isolated from man and animals
Acta Pathol Microbiol Immunol Scand B, 93 (1), 27-35
DOI 10.1111/j.1699-0463.1985.tb02847.x, PubMed 3984743

BERGAN T (1985)
CHEMOTHERAPY OF URINARY-TRACT INFECTIONS
Clin. Ther., 7 B, 13-27

Kalager T, Digranes A, Salveson A, Bergan T (1985)
Pharmacokinetics of brodimoprim in serum and skin blister fluid
Chemotherapy, 31 (6), 405-9
DOI 10.1159/000238367, PubMed 4075857

BERGAN T (1985)
PENETRATION OF ANTIBIOTICS INTO HUMAN PERIPHERAL LYMPH
Scand. J. Infect. Dis. (44), 41-45

Bergan T (1985)
Penetration of antibiotics into human peripheral lymph
Scand J Infect Dis Suppl, 44, 41-5
PubMed 3860936

Bergan T, Olszewski WL, Engeset A (1985)
Temocillin penetration of peripheral lymph
Drugs, 29 Suppl 5, 114-7
DOI 10.2165/00003495-198500295-00024, PubMed 4029013

Bergan T, Carlsen IB (1985)
Effect of antibiotics eliminated by first order kinetics
J Antimicrob Chemother, 15 Suppl A, 147-52
DOI 10.1093/jac/15.suppl_a.147, PubMed 3980326

BERGAN T (1985)
ANTIBACTERIAL ACTIVITY AND PHARMACOKINETICS OF NITROIMIDAZOLES - A REVIEW
Scand. J. Infect. Dis. (46), 64-71

Bergan T (1985)
Antibacterial activity and pharmacokinetics of nitroimidazoles. A review
Scand J Infect Dis Suppl, 46, 64-71
PubMed 3865352

Kalager T, Digranes A, Bergan T, Solberg CO (1984)
The pharmacokinetics of ceftriaxone in serum, skin blister and thread fluid
J Antimicrob Chemother, 13 (5), 479-85
DOI 10.1093/jac/13.5.479, PubMed 6330020

Bergan T, Aase S, Leinebo O, Harbitz T, Olsen A, Liavag I (1984)
Pharmacokinetics of metronidazole and its major metabolite after a high intravenous dose
Scand J Gastroenterol Suppl, 91, 113-23
PubMed 6588488

Roland M, Bergan T, Andenaes K, Bjerkeset T, Brabrand G, Erichsen H, Flørenes T, Garberg O, Glauer H, Holter O (1984)
Prophylactic regimens in colorectal surgery. Comparison between metronidazole used alone or in combination with either ampicillin or doxycycline
Scand J Gastroenterol Suppl, 90, 37-52
PubMed 6588482

BERGAN T, FOTLAND MH (1984)
INVITRO INTERACTIONS BETWEEN METRONIDAZOLE OR TINIDAZOLE AND AMPICILLIN, DOXYCYCLINE AND CO-TRIMOXAZOLE ON THE EFFECT AGAINST ANAEROBIC-BACTERIA
Scand. J. Gastroenterol., 19 91, 95-101

Fuglesang JE, Bergan T (1984)
Antibacterial activity and kill kinetics of ampicillin/sulbactam (CP-45899) combinations against Escherichia coli and Klebsiella aerogenes
Infection, 12 (1), 46-50
DOI 10.1007/BF01641025, PubMed 6323321

BERGAN T (1984)
PATHOGENICITY OF ANAEROBIC-BACTERIA
Scand. J. Gastroenterol., 19 91, 1-11

SOLHAUG JH, BERGAN T, LEINEBO O, ROSSELAND AR, SPADA L, VAAGENES F (1984)
THE PHARMACOKINETICS OF ONE SINGLE PREOPERATIVE DOSE OF METRONIDAZOLE OR TINIDAZOLE
Scand. J. Gastroenterol., 19 90, 89-96

Bergan T, Vangdal M, Salveson A (1984)
Evaluation of Minitec and API as rapid diagnostic methods for anaerobic bacteria
Scand J Gastroenterol Suppl, 91, 103-11
PubMed 6377470

BERGAN T (1984)
MICROBIAL SPECTRUM AND ANTIMICROBIAL SUSCEPTIBILITY IN INFECTIONS AFTER GASTROINTESTINAL SURGERY
Scand. J. Gastroenterol., 19 90, 1-14

BERGAN T (1984)
PHARMACOKINETICS OF BETA-LACTAM ANTIBIOTICS
Scand. J. Infect. Dis. (42), 83-98

Bergan T, Leinebo O, Blom-Hagen T, Salvesen B (1984)
Pharmacokinetics and bioavailability of metronidazole after tablets, suppositories and intravenous administration
Scand J Gastroenterol Suppl, 91, 45-60
PubMed 6588489

VANGDAL M, BERGAN T (1984)
INVITRO ACTIVITY OF AZLOCILLIN, AMINOGLYCOSIDES AND OXACINS AGAINST PSEUDOMONAS-AERUGINOSA
Drug Exp. Clin. Res, 10 (7), 433-436

Solhaug JH, Bergan T, Leinebø O, Rosseland AR, Spada L, Vaagenes F (1984)
The pharmacokinetics of one single preoperative dose of metronidazole or tinidazole
Scand J Gastroenterol Suppl, 90, 89-96
PubMed 6588485

BERGAN T, VANGDAL M, SALVESON A (1984)
EVALUATION OF MINITEC AND API AS RAPID DIAGNOSTIC METHODS FOR ANAEROBIC-BACTERIA
Scand. J. Gastroenterol., 19 91, 103-111

Bergan T (1984)
Microbial spectrum and antimicrobial susceptibility in infections after gastrointestinal surgery
Scand J Gastroenterol Suppl, 90, 1-14
PubMed 6588478

SALVESEN B, LEINEBO O, BERGAN T (1984)
ASSAY OF METRONIDAZOLE BY HPLC COMPARED WITH MICROBIAL METHOD
Scand. J. Gastroenterol., 19 91, 31-43

Loennechen T, Bergan T, Sydnes LK, Aasen AJ (1984)
Synthesis of D-Ala--D-Ala analogues with postulated antibacterial activity
Acta Chem Scand B, 38 (8), 647-55
DOI 10.3891/acta.chem.scand.38b-0647, PubMed 6524219

Cocchetto JF, Cocchetto DM, Bjornsson TD, Bergan T (1984)
Initial slope technique for estimation of the apparent volume of distribution during constant-rate intravenous infusion
J Pharm Sci, 73 (1), 58-62
DOI 10.1002/jps.2600730115, PubMed 6694084

SOREIDE O, LEINEBO O, BERGAN T, BAKKEVOLD K, SALVESEN B, ULVIK NM (1984)
COMPARATIVE PHARMACOKINETICS OF METRONIDAZOLE AND TINIDAZOLE USED AS SINGLE DOSE PROPHYLACTIC AGENTS
Scand. J. Gastroenterol., 19 90, 97-106

Salvesen B, Leinebo O, Bergan T (1984)
Assay of metronidazole by HPLC compared with microbial method
Scand J Gastroenterol Suppl, 91, 31-43
PubMed 6377472

BERGAN T, ENGESET A (1984)
PENETRATION OF ANTIBIOTICS TO TISSUES AND INFECTED FOCI
Scand. J. Gastroenterol., 19 90, 29-34

Hagen EA, Bergan T, Aasen AJ (1984)
Synthesis of analogs of D-Ala-D-Ala as potential inhibitors of bacterial cell wall biosynthesis
Acta Chem Scand B, 38 (1), 5-14
DOI 10.3891/acta.chem.scand.38b-0005, PubMed 6375222

Bergan T (1984)
Pharmacokinetics of beta-lactam antibiotics
Scand J Infect Dis Suppl, 42, 83-98
PubMed 6597564

VANGDAL M, BERGAN T (1984)
INVITRO SYNERGISTIC ACTIVITY OF NORFLOXACIN AND AMPHOTERICIN-B AGAINST FUNGI
Drug Exp. Clin. Res, 10 (7), 443-444

Søreide O, Leinebø O, Bergan T, Bakkevold K, Salvesen B, Ulvik NM (1984)
Comparative pharmacokinetics of metronidazole and tinidazole used as single dose prophylactic agents
Scand J Gastroenterol Suppl, 90, 97-106
PubMed 6588486

BERGAN T, AASE S, LEINEBO O, ROLAND M, HARBITZ T, OLSEN A, LIAVAG I (1984)
PHARMACOKINETICS OF METRONIDAZOLE AND ITS MAJOR METABOLITE AFTER A HIGH INTRAVENOUS DOSE
Scand. J. Gastroenterol., 19 91, 113-123

Bergan T, Engeset A (1984)
Penetration of antibiotics to tissues and infected foci
Scand J Gastroenterol Suppl, 90, 29-34
PubMed 6588481

BERGAN T, LEINEBO O, BLOMHAGEN T, SALVESEN B (1984)
PHARMACOKINETICS AND BIOAVAILABILITY OF METRONIDAZOLE AFTER TABLETS, SUPPOSITORIES AND INTRAVENOUS ADMINISTRATION
Scand. J. Gastroenterol., 19 91, 45-60

Michalsen H, Monn E, Bergan T, Churg J, Johannessen JV (1984)
Renal biopsies in cystic fibrosis
Pathol Res Pract, 178 (3), 261-7
DOI 10.1016/S0344-0338(84)80108-9, PubMed 6718276

ROLAND M, BERGAN T, ANDENAES K, BJERKESET T, BRABRAND G, ERICHSEN H, FLORENES T, GARBERG O, GLAUER H, HOLTER O, KIERULF KH, KUFAAS J, LIAVAG I, MOEN OO, ODLAND G, ROSSELAND A, SALKOWITSCH B, SOLHAUG JH, STORDAHL A, SOREIDE O, THORSEN G, TRONNES S, VANGDAL M, WIIG JN, ODEGARD O et al. (1984)
PROPHYLACTIC REGIMENS IN COLORECTAL SURGERY - COMPARISON BETWEEN METRONIDAZOLE USED ALONE OR IN COMBINATION WITH EITHER AMPICILLIN OR DOXYCYCLINE
Scand. J. Gastroenterol., 19 90, 37-52

Bergan T, Fotland MH (1984)
In vitro interactions between metronidazole or tinidazole and ampicillin, doxycycline and co-trimoxazole on the effect against anaerobic bacteria
Scand J Gastroenterol Suppl, 91, 95-101
PubMed 6610923

Bergan T, Engeset A, Olszewski W, Sjövall J (1983)
Distribution to human peripheral lymph of amoxycillin and of ampicillin from the oral prodrug bacampicillin
J Antimicrob Chemother, 12 (5), 497-502
DOI 10.1093/jac/12.5.497, PubMed 6671926

Bergan T (1983)
Bronchitis caused by the fungus Cladosporium carrionii usually considered apathogenic, possibly by an allergenic mechanism
Mykosen, 26 (11), 547-50
PubMed 6656842

Bergan T, Engeset A, Olszewski W (1983)
Temocillin in peripheral lymph
J Antimicrob Chemother, 12 (1), 59-63
DOI 10.1093/jac/12.1.59, PubMed 6619047

Olsvik O, Lund A, Berdal BP, Bergan T (1983)
Differences in bindings to the GM1 receptor by heat-labile enterotoxin of human and porcine Escherichia coli strains
NIPH Ann, 6 (1), 5-15
PubMed 6353279

Bergan T (1983)
Review of the pharmacokinetics of mezlocillin
J Antimicrob Chemother, 11 Suppl C, 1-16
DOI 10.1093/jac/11.suppl_c.1, PubMed 6352604

Bergan T (1983)
Review of the pharmacokinetics and dose dependency of azlocillin in normal subjects and patients with renal insufficiency
J Antimicrob Chemother, 11 Suppl B, 101-14
DOI 10.1093/jac/11.suppl_b.101, PubMed 6352598

Bergan T, Vaksvik AK (1983)
Taxonomic implications of quantitative transformation in Acinetobacter calcoaceticus
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol, 254 (2), 214-28
DOI 10.1016/S0174-3031(83)80147-4, PubMed 6586037

Bergan T (1983)
Propulsive load administration and bacampicillin
Singapore Med J, 24 (2), 82-9
PubMed 6612360

Holter O, Bergan T, Flørenes T, Leinebø O (1983)
Penetration of metronidazole to tissues
J Antimicrob Chemother, 11 (4), 357-60
DOI 10.1093/jac/11.4.357, PubMed 6853405

Bergan T, Vaksvik AK (1983)
Factors affecting quantitative transformation of streptomycin resistance markers in Acinetobacter calcoaceticus
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol, 254 (2), 197-213
DOI 10.1016/S0174-3031(83)80146-2, PubMed 6586036

Bergan T (1983)
Diagnostic considerations and sample collection for anaerobic bacteria
Scand J Gastroenterol Suppl, 85, 5-14
PubMed 6353555

Bergan T, Lernestedt JO (1983)
Antibiotic resistance in staphylococci from a hospital environment
Chemotherapy, 29 (1), 28-36
DOI 10.1159/000238170, PubMed 6831971

BERGAN T (1983)
ANAEROBIC-BACTERIA AS CAUSE OF INFECTIONS IN FEMALE GENITAL ORGANS
Scand. J. Gastroenterol., 18 85, 37-47

BERGAN T, GRIMONT PAD, GRIMONT F (1983)
FATTY-ACIDS OF SERRATIA DETERMINED BY GAS-CHROMATOGRAPHY
Curr. Microbiol., 8 (1), 7-11
DOI 10.1007/BF01567306

Bruun JN, Bergan T, Ostby N, Bredesen JE, Lunde PK (1983)
Pharmacokinetics of methioprim in human volunteers
Chemotherapy, 29 (3), 178-83
DOI 10.1159/000238194, PubMed 6872616

Fuglesang JE, Bergan T (1983)
Antibacterial activity and kill kinetics of amoxicillin-clavulanic acid combinations against Escherichia coli and Klebsiella aerogenes
Infection, 11 (6), 329-35
DOI 10.1007/BF01641359, PubMed 6365790

LIU PV, MATSUMOTO H, KUSAMA H, BERGAN T (1983)
SURVEY OF HEAT-STABLE, MAJOR SOMATIC ANTIGENS OF PSEUDOMONAS-AERUGINOSA
Int. J. Syst. Bacteriol., 33 (2), 256-264
DOI 10.1099/00207713-33-2-256

KOSMIDIS J, KAMPF D, LODE, BERGAN T, NEU HC, KEIGHLEY MRB, FASS RJ, SABBAJ (1983)
MEZLOCILLIN - DISCUSSION
J. Antimicrob. Chemother., 11 C, 105-106

BERGAN T (1983)
DIAGNOSTIC CONSIDERATIONS AND SAMPLE COLLECTION FOR ANAEROBIC-BACTERIA
Scand. J. Gastroenterol., 18 85, 5-14

Bergan T, Vangdal M (1983)
In vitro activity of antifungal agents against yeast species
Chemotherapy, 29 (2), 104-10
DOI 10.1159/000238182, PubMed 6301773

Bergan T, Brodwall EK, Larsen EW (1983)
Relationship between pharmacokinetics and bioavailability of cefroxadine (CGP 9000) and renal function
Chemotherapy, 29 (3), 163-73
DOI 10.1159/000238192, PubMed 6872614

Bergan T (1982)
The role of broad-spectrum antibiotics and diagnostic problems in urinary tract infections
Arch Intern Med, 142 (11), 1993-9
DOI 10.1001/archinte.142.11.1993, PubMed 6922692

Bergan T, Engeset A, Olszewski W, Josefsson K, Larsen N (1982)
Penetration of erythromycin into human peripheral lymph
J Antimicrob Chemother, 10 (4), 319-24
DOI 10.1093/jac/10.4.319, PubMed 7142079

Bergan T, Kalager T, Hellum KB, Solberg CO (1982)
Penetration of cefotaxime and desacetylcefotaxime into skin blister fluid
J Antimicrob Chemother, 10 (3), 193-6
DOI 10.1093/jac/10.3.193, PubMed 6292157

Bergan T, Hollum AB, Vangdal M (1982)
Evaluation of four commercial biochemical test systems for identification of yeasts
Eur J Clin Microbiol, 1 (4), 217-22
DOI 10.1007/BF02019711, PubMed 6756911

Bergan T, Fotland MH, Sund RB (1982)
Interaction between diphenolic laxatives and intestinal bacteria in vitro
Acta Pharmacol Toxicol (Copenh), 51 (2), 165-72
DOI 10.1111/j.1600-0773.1982.tb01009.x, PubMed 6896788

Bergan T (1982)
[Penetration of antibiotics into peripheral infection foci]
Wien Klin Wochenschr, 94 (13), 331-40
PubMed 7135978

Olsvik O, Bergan T, Oye I (1982)
Chlorpromazine inhibition of enterotoxin-induced fluid secretion and cAMP production in rat ileum
Eur J Pharmacol, 80 (4), 369-76
DOI 10.1016/0014-2999(82)90082-6, PubMed 6286324

Josefsson K, Bergan T, Magni L (1982)
Dose-related pharmacokinetics after oral administration of a new formulation of erythromycin base
Br J Clin Pharmacol, 13 (5), 685-91
DOI 10.1111/j.1365-2125.1982.tb01437.x, PubMed 7082537

Gjønnaess H, Dalaker K, Anestad G, Mårdh PA, Kvile G, Bergan T (1982)
Pelvic inflammatory disease: etiologic studies with emphasis on chlamydial infection
Obstet Gynecol, 59 (5), 550-5
PubMed 6803199

Berdal BP, Hushovd O, Olsvik O, odegård OR, Bergan T (1982)
Demonstration of extracellular proteolytic enzymes from Legionella species strains by using synthetic chromogenic peptide substrates
Acta Pathol Microbiol Immunol Scand B, 90 (2), 119-23
DOI 10.1111/j.1699-0463.1982.tb00092.x, PubMed 7044037

Olsvik O, Hushovd OT, Berdal BP, Bergan T, Mathiesen M (1982)
Production of enterotoxin by Escherichia coli at four, twenty-two and thirty-seven degrees centigrade
Eur J Clin Microbiol, 1 (1), 12-6
DOI 10.1007/BF02014134, PubMed 6756901

Kalager T, Digranes A, Bakke K, Hellum KB, Bergan T, Solberg CO (1982)
Cefotaxime in serious infections--a clinical and pharmacokinetic study
J Antimicrob Chemother, 9 (2), 157-63
DOI 10.1093/jac/9.2.157, PubMed 6277842

Bergan T, Williams JD (1982)
Dose dependence of piperacillin pharmacokinetics
Chemotherapy, 28 (3), 153-9
DOI 10.1159/000238070, PubMed 6212203

Bergan T (1982)
Biology of Chlamydia
Scand J Infect Dis Suppl, 32, 11-5
PubMed 6958006

Onsrud M, Bergan T, Gjønnaess H (1982)
Antibiotic levels in plasma and peritoneal fluid after amoxycillin, ampicillin, and bacampicillin treatment for pelvic inflammatory disease
Acta Obstet Gynecol Scand, 61 (3), 247-51
DOI 10.3109/00016348209156566, PubMed 7124355

BERGAN T (1982)
BIOLOGY OF CHLAMYDIA
Scand. J. Infect. Dis. (32), 11-15

Bergan T, Thorsteinsson SB, Steingrimsson O (1982)
Dose-dependent pharmacokinetics of azlocillin compared to mezlocillin
Chemotherapy, 28 (3), 160-70
DOI 10.1159/000238071, PubMed 6212204

BERGAN T, HELLIUM KB, SCHREINER A, DIGRANES A, JOSEFSSON K (1982)
PASSAGE OF ERYTHROMYCIN INTO HUMAN SUCTION SKIN BLISTERS
Curr. Ther. Res.-Clin. Exp., 32 (4), 597-603

Josefsson K, Bergan T, Magni L, Pring BG, Westerlund D (1982)
Pharmacokinetics of bacmecillinam and pivmecillinam in volunteers
Eur J Clin Pharmacol, 23 (3), 249-52
DOI 10.1007/BF00547563, PubMed 6293834

Josefsson K, Steinbakk M, Bergan T, Midtvedt T, Magni L (1982)
Pharmacokinetics of a new, microencapsulated erythromycin base after repeated oral doses
Chemotherapy, 28 (3), 176-84
DOI 10.1159/000238073, PubMed 7094658

Bergan T, Larsen EW, Brodwall EK (1982)
Pharmacokinetics of a new cephalosporin, cefotaxime (HR 756) in patients with different renal functions
Chemotherapy, 28 (2), 85-104
DOI 10.1159/000238063, PubMed 6280931

Fuglesang JE, Bergan T (1982)
Antibacterial kinetics of ampicillin against Escherichia coli under simulated in vivo conditions
Infection, 10 (1), 31-4
DOI 10.1007/BF01640835, PubMed 7040252

Josefsson K, Bergan T (1982)
Pharmacokinetics of phenoxymethylpenicillin in volunteers
Chemotherapy, 28 (4), 241-6
DOI 10.1159/000238084, PubMed 6811219

MICHALSEN H, BERGAN T (1982)
PHARMACOKINETICS OF ANTIBIOTICS IN CHILDREN WITH CYSTIC-FIBROSIS WITH PARTICULAR REFERENCE TO NETILMICIN
ACTA PAEDIATR SCAND (301), 101-105

Bergan T, Michalsen H (1982)
Pharmacokinetic assessment of netilmicin in newborns and older children
Infection, 10 (3), 153-8
DOI 10.1007/BF01640766, PubMed 7107013

Helgesen KG, Andersen R, Bergan T (1981)
Prevention of bacterial spread in a respirator circuit
J Oslo City Hosp, 31 (11), 133-5
PubMed 6947083

Salveson A, Bergan T (1981)
Contamination of chlorhexidine cream used to prevent ascending urinary tract infections
J Hyg (Lond), 86 (3), 295-301
DOI 10.1017/s0022172400069047, PubMed 7240733

Michalsen H, Bergan T (1981)
Pharmacokinetics of netilmicin in children with and without cystic fibrosis
Antimicrob Agents Chemother, 19 (6), 1029-31
DOI 10.1128/AAC.19.6.1029, PubMed 7271272

Dalaker K, Gjønnaess H, Kvile G, Urnes A, Anestad G, Bergan T (1981)
Chlamydia trachomatis as a cause of acute perihepatitis associated with pelvic inflammatory disease
Br J Vener Dis, 57 (1), 41-3
DOI 10.1136/sti.57.1.41, PubMed 7470834

Bergan T, Solberg R (1981)
Assay of cefotaxime by high-pressure-liquid chromatography
Chemotherapy, 27 (3), 155-65
DOI 10.1159/000237972, PubMed 6262021

Brodwall EK, Orjavik O, Bergan T (1981)
Kidney transport of cefapirin in normal and impaired renal function
Arzneimittelforschung, 31 (12), 2157-9
PubMed 7199318

BERGAN T, KALLINGS IM (1981)
SEROLOGICAL RESPONSE TO SALMONELLA-TYPHI O-ANTIGENS DURING INFECTION BY LEGIONELLA PNEUMOPHILA
Infection, 9 (4), 201-203
DOI 10.1007/BF01640980

BERGAN T, MAGNI L (1981)
ASSAY OF ANTIBIOTICS - A SPEARMAN-KARBER BROTH DILUTION PROCEDURE COMPARED WITH TRADITIONAL METHODS
Microbiologica, 4 (1), 73-86

Roland M, Bergan T, Jakobsen A, Liavåg I (1981)
Effect of metronidazole and ampicillin on patients with gangrenous or perforated appendicitis. A comparative study
Scand J Infect Dis Suppl, 26, 92-5
PubMed 6941464

Thorsteinsson SB, Steingrimsson O, Asmundsson P, Bergan T (1981)
Pharmacokinetics of mezlocillin during haemodialysis
Scand J Infect Dis Suppl, 29, 59-63
PubMed 6458883

MICHALSEN H, BERGAN T (1981)
AZLOCILLIN WITH AND WITHOUT AN AMINOGLYCOSIDE AGAINST RESPIRATORY-TRACT INFECTIONS IN CHILDREN WITH CYSTIC-FIBROSIS
Scand. J. Infect. Dis. (29), 92-97

Bergan T, Bjerke PE, Fausa O (1981)
Pharmacokinetics of metronidazole in patients with enteric disease compared to normal volunteers
Chemotherapy, 27 (4), 233-8
DOI 10.1159/000237985, PubMed 7249785

BERGAN T (1981)
PATHOGENETIC FACTORS OF PSEUDOMONAS-AERUGINOSA
Scand. J. Infect. Dis. (29), 7-12

Schreiner A, Bergan T, Hellum KB, Digranes A (1981)
Pharmacokinetics of ampicillin in serum and in dermal suction blisters after oral administration of bacampicillin
Rev Infect Dis, 3 (1), 125-31
DOI 10.1093/clinids/3.1.125, PubMed 7221355

BERGAN T, STARR MP (1981)
SEQUENTIAL PRINCIPAL COMPONENTS-ANALYSIS, A TOOL FOR CLUSTER DETECTION IN LARGE BACTERIOPHAGE-TYPING DATA SAMPLES
Curr. Microbiol., 6 (1), 1-6
DOI 10.1007/BF01566717

Salveson A, Bergan T (1981)
Enterobacteria differentiated by gas-liquid chromatography of metabolites
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol, 250 (1-2), 104-12
PubMed 7198354

GJONNAESS H, DALAKER K, URNES A, NORLING B, KVILE G, MARDH PA, ANESTAD G, BERGAN T (1981)
TREATMENT OF PELVIC INFLAMMATORY DISEASE EFFECTS OF LYMECYCLINE AND CLINDAMYCINE
Curr. Ther. Res.-Clin. Exp., 29 (6), 885-892

OLSVIK O, BERGAN T, OYE I (1981)
SHEDDING OF INTESTINAL EPITHELIUM INDUCED BY CHLORPROMAZINE AS MECHANISM INHIBITING ENTERO-TOXIN DIARRHEA
Curr. Microbiol., 6 (5), 263-268
DOI 10.1007/BF01566874

Bergan T, Solberg R (1981)
Comparison of microbiological and high pressure liquid chromatographic assays of the new cephalosporin cefroxadine
Methods Find Exp Clin Pharmacol, 3 (3), 179-82
PubMed 7253774

BERGAN T (1981)
OVERVIEW OF ACYLUREIDOPENICILLIN PHARMACOKINETICS
Scand. J. Infect. Dis. (29), 33-48

Fuglesang JE, Bergan T, Bielecki T, Naterstad A, Namork E (1981)
Inhibitory activity and bactericidal kinetics of mecillinam/ampicillin combinations against Enterobacteriaceae, Pseudomonas and Acinetobacter
Infection, 9 (6), 290-5
DOI 10.1007/BF01640994, PubMed 6277795

Bergan T (1981)
Pharmacokinetics of tissue penetration of antibiotics
Rev Infect Dis, 3 (1), 45-66
DOI 10.1093/clinids/3.1.45, PubMed 7013000

KAPPERUD G, BERGAN T, LASSEN J (1981)
NUMERICAL TAXONOMY OF YERSINIA-ENTEROCOLITICA AND YERSINIA-ENTEROCOLITICA-LIKE BACTERIA
Int. J. Syst. Bacteriol., 31 (4), 401-419
DOI 10.1099/00207713-31-4-401

Bergan T, Orjavik O, Brodwall EK (1981)
Pharmacokinetics of cefapirin in patients with normal and impaired renal functions
Arzneimittelforschung, 31 (10), 1773-6
PubMed 7198453

ROLAND M, BERGAN T, JAKOBSEN A, LIAVAG I (1981)
EFFECT OF METRONIDAZOLE AND AMPICILLIN ON PATIENTS WITH GANGRENOUS OR PERFORATED APPENDICITIS - A COMPARATIVE-STUDY
Scand. J. Infect. Dis. (26), 92-95

Michalsen H, Bergan T (1981)
Azlocillin with and without an aminoglycoside against respiratory tract infections in children with cystic fibrosis
Scand J Infect Dis Suppl, 29, 92-7
PubMed 6947408

THORSTEINSSON SB, STEINGRIMSSON O, ASMUNDSSON P, BERGAN T (1981)
PHARMACOKINETICS OF MEZLOCILLIN DURING HEMODIALYSIS
Scand. J. Infect. Dis. (29), 59-63

Andersen R, Bergan T, Halvorsen K, Kallings I, Orstavik I (1981)
Legionnaires' disease combined with erythema multiforme in a 3-year-old boy
Acta Paediatr Scand, 70 (3), 427-30
DOI 10.1111/j.1651-2227.1981.tb16579.x, PubMed 7246139

BERGAN T, GJONNAESS H (1981)
PENETRATION OF ERYTHROMYCIN TO FEMALE PELVIC ORGANS
Curr. Ther. Res.-Clin. Exp., 30 (5), 597-603

Salveso A, Bergan T (1980)
[Anaerobic infections. Pathogenesis, clinical signs, and treatment]
Tidsskr Nor Laegeforen, 100 (31), 1836-40
PubMed 7456039

Salveson A, Bergan T (1980)
[Anaerobic bacteria. Bacteriology and laboratory diagnosis]
Tidsskr Nor Laegeforen, 100 (31), 1833-5
PubMed 7006144

Giercksky KE, Fuglesang J, Christiansen E, Johnson JA, Bergan T (1980)
Short term chemotherapeutic prophylaxis in gastrointestinal operations
Surg Gynecol Obstet, 151 (3), 349-52
PubMed 7404301

Bergan T (1980)
[New antifungal agents: econazole and micronazole]
Tidsskr Nor Laegeforen, 100 (10), 577-8
PubMed 7385115

Vangdal M, Bergan T (1980)
Radioimmunoassay of tobramycin compared to microbial methods
Methods Find Exp Clin Pharmacol, 2 (2), 61-4
PubMed 7339329

Bergan T, Arnold E, Withander L (1980)
Comparison of metronidazole assay by microbiological and chemical methods
Methods Find Exp Clin Pharmacol, 2 (3), 145-50
PubMed 6279985

Bergan T (1980)
[Mecillinam]
Tidsskr Nor Laegeforen, 100 (3), 175-76
PubMed 6247780

Bergan T, Olsvik O (1980)
[Production and purification of thermolabile enterotoxin of Escherichia coli (author's transl)]
Infection, 8 Suppl 3, S 226-33
PubMed 6997202

Bergan T, Brodwall EK, Orjavik O (1980)
Pharmacokinetics of the new broad spectrum penicillin CP-33994-2
Arzneimittelforschung, 30 (7), 1144-7
PubMed 7191297

Bergan T (1980)
Pharmacokinetics of a new cephalosporin, CGP 9000 (cefroxadine), in healthy volunteers
Chemotherapy, 26 (4), 225-30
DOI 10.1159/000237910, PubMed 7389422

BLOMHAGEN T, BERGAN T, LIAVAG I (1980)
PROPHYLACTIC METRONIDAZOLE IN ELECTIVE COLO-RECTAL SURGERY
ACTA CHIR SCAND, 146 (1), 71-75

Hagen TB, Bergan T, Liavåg I (1980)
Prophylactic metronidazole in electrive colo-rectal surgery
Acta Chir Scand, 146 (1), 71-5
PubMed 6990670

Bergan T, Arnold E (1980)
Pharmacokinetics of metronidazole in healthy adult volunteers after tablets and suppositories
Chemotherapy, 26 (4), 231-41
DOI 10.1159/000237911, PubMed 7389423

BERGAN T, OLSVIK O (1980)
PRODUCTION AND PURIFICATION OF THERMOLABILE ENTERO-TOXIN OF ESCHERICHIA-COLI
Infection, 8 3, 226-233
DOI 10.1007/BF01639586

Bergan T (1980)
Pharmacokinetic considerations for antibiotic treatment of oral infections
Swed Dent J, 4 (1-2), 17-21
PubMed 6930109

Michalsen H, Bergan T (1980)
Azlocillin in respiratory tract infections with Pseudomonas aeruginosa in children with cystic fibrosis
Chemotherapy, 26 (2), 135-40
DOI 10.1159/000237895, PubMed 7363708

Bergan T, Sørensen G (1980)
Pharmacokinetics of azidocillin in healthy adults
Arzneimittelforschung, 30 (12), 2185-91
PubMed 6894241

Bergan T, Carlsen IB (1980)
Bacterial kill rates of amoxycillin and ampicillin at exponentially diminishing concentrations simulating in vivo conditions
Infection, Suppl 1, 103-8
DOI 10.1007/BF01644943, PubMed 6995345

Bergan T, Carlsen IB, Fuglesang JE (1980)
An in vitro model for monitoring bacterial responses to antibiotic agents under simulated in vivo conditions
Infection, Suppl 1, 096-10
DOI 10.1007/BF01644942, PubMed 6772578

MICHALSEN H, HALVORSEN K, BERGAN T (1980)
NETILMICIN IN THE TREATMENT OF NEONATES WITH MODERATE AND SEVERE INFECTIONS
Scand. J. Infect. Dis. (23), 146-149

Michalsen H, Halvorsen K, Bergan T (1980)
Netilmicin in the treatment of neonates with moderate and severe infections
Scand J Infect Dis Suppl, Suppl 23, 146-50
PubMed 6937960

Sander S, Bergan T, Fossberg E (1980)
Piperacillin in the treatment of urinary tract infections
Chemotherapy, 26 (2), 141-4
DOI 10.1159/000237896, PubMed 6444867

Bergan T, Brodwall EK, Wiik-Larsen E (1979)
Mezlocillin pharmacokinetics in patients with normal and impaired renal functions
Antimicrob Agents Chemother, 16 (5), 651-4
DOI 10.1128/AAC.16.5.651, PubMed 526008

Bergan T, Engeset A, Olszewski W, Solberg R (1979)
Pharmacokinetics of bacampicillin and bacmecillinam in plasma and peripheral lymph
Lymphology, 12 (2), 85-94
PubMed 226808

Bergan T (1979)
[Metronidazole]
Tidsskr Nor Laegeforen, 99 (6), 335-6
PubMed 425104

Ekström B, Forsgren U, Ortengren B, Bergan T (1979)
Development of sulphonamide-trimethoprim combinations for urinary tract infections. Part I: Comparison of the antibacterial effect of sulphonamides alone and in combination with trimethoprim
Infection, 7 Suppl 4, S359-66
DOI 10.1007/BF01639014, PubMed 389812

Bergan T, Kozaczek W (1979)
Epidemiological markers for Pseudomonas aeruginosa. VII. Nosocomial occurrence in urological ward. Comparison of two phage typing sets, pyocine typing, and serogrouping
Arch Immunol Ther Exp (Warsz), 27 (3), 447-58
PubMed 112947

Bergan T, Brodwall EK, Vik-Mo H, Anstad U (1979)
Pharmacokinetics of sulphadiazine, sulphamethoxazole and trimethoprim in patients with varying renal function
Infection, 7 Suppl 4, S382-7
DOI 10.1007/BF01639017, PubMed 511352

Skjerven O, Bergan T (1979)
Double-blind comparison of sulphonamide-trimethoprim combinations in acute uncomplicated urinary tract infections
Infection, 7 Suppl 4, S398-400
DOI 10.1007/BF01639020, PubMed 389813

Bergan T, Skjerven O (1979)
Comparison of sulfamethoxazole alone and combined with trimethoprim in urinary tract infections
Infection, 7 (1), 14-6
DOI 10.1007/BF01640549, PubMed 370019

Bergan T, Michalsen H (1979)
Pharmacokinetics of azlocillin in children with cystic fibrosis
Arzneimittelforschung, 29 (12a), 1955-7
PubMed 543899

Ortengren B, Fellner H, Bergan T (1979)
Development of sulphonamide-trimethoprim combinations for urinary tract infections. Part 2: Comparative pharmacokinetics of five sulphonamides
Infection, 7 Suppl 4, S367-70
DOI 10.1007/BF01639015, PubMed 511350

Bergan T, Dobloug I, Liavåg I (1979)
Bacterial isolates in cholecystitis and cholelithiasis
Scand J Gastroenterol, 14 (5), 625-31
DOI 10.3109/00365527909181401, PubMed 386479

Ohlsson H, Bergan T (1979)
Comparison between the pharmacokinetic properties of mezlocillin when given intravenously as a bolus injection or as an infusion
Arzneimittelforschung, 29 (12a), 1958-9
PubMed 543900

Onsrud M, Gjønnaess H, Bergan T (1979)
Amoxycillin absorption and penetration in pelvic inflammatory disease
Acta Obstet Gynecol Scand, 58 (4), 401-3
DOI 10.3109/00016347909154604, PubMed 525275

Ortengren B, Magni L, Bergan T (1979)
Development of sulphonamide-trimethoprim combinations for urinary tract infections. Part 3: Pharmacokinetic characterization of sulphadiazine and sulphamethoxazole given with trimethoprim
Infection, 7 Suppl 4, S371-81
DOI 10.1007/BF01639016, PubMed 511351

Bergan T, Skjerven O (1979)
Double blind comparison of short and medium term sulfonamides, sulfamethizole and sulfamethoxazole, in uncomplicated acute urinary tract infections
Scand J Infect Dis, 11 (3), 219-23
DOI 10.3109/inf.1979.11.issue-3.08, PubMed 392739

Bergan T (1978)
Pharmacokinetics of mezlocillin in healthy volunteers
Antimicrob Agents Chemother, 14 (6), 801-6
DOI 10.1128/AAC.14.6.801, PubMed 742869

Bergan T (1978)
[Penicillins at a milestone]
Tidsskr Nor Laegeforen, 98 (27), 1331
PubMed 250302

Bergan T, Hertzenberg S, Thune PO (1978)
[Acne vulgaris and antibiotics]
Tidsskr Nor Laegeforen, 98 (25), 1220-1
PubMed 151349

Bergan T (1978)
[Kanamycin]
Tidsskr Nor Laegeforen, 98 (22), 1017-8
PubMed 684699

Bergan T (1978)
[Erythromycin instead of tetracyclines to children]
Tidsskr Nor Laegeforen, 98 (22), 1020
PubMed 684704

Bergan T (1978)
Pharmacokinetic comparison of oral bacampicillin and parenteral ampicillin
Antimicrob Agents Chemother, 13 (6), 971-4
DOI 10.1128/AAC.13.6.971, PubMed 677863

Bergan T (1978)
[Combination of amphotericin B and 5-fluorocytosine]
Tidsskr Nor Laegeforen, 98 (13), 701-3
PubMed 653679

Bergan T, Melby K (1978)
[Amikacin and tobramycin]
Tidsskr Nor Laegeforen, 98 (12), 639-41
PubMed 653664

Bergan T, Melby K (1978)
[Precautionary measures in the use of aminoglycosides]
Tidsskr Nor Laegeforen, 98 (12), 641
PubMed 653666

Bergan T, Digranes A, Schreiner A (1978)
Absorption, distribution and elimination of cefazolin in patients with normal renal function
Chemotherapy, 24 (5), 277-82
DOI 10.1159/000237793, PubMed 352636

Bergan T, Bratlid D, Brøndbo A (1978)
Pharmacokinetics of bacampicillin in infants
J Antimicrob Chemother, 4 (1), 79-84
DOI 10.1093/jac/4.1.79, PubMed 624693

Bergan T (1978)
Kinetics of tissue penetration. Are high plasma peak concentrations or sustained levels preferable for effective antibiotic therapy?
Scand J Infect Dis Suppl (14), 36-46
PubMed 279985

BERGAN T (1978)
KINETICS OF TISSUE PENETRATION - ARE HIGH PLASMA PEAK CONCENTRATIONS OR SUSTAINED LEVELS PREFERABLE FOR EFFECTIVE ANTIBIOTIC THERAPY
Scand. J. Infect. Dis. (14), 36-46

Stearns NS, Roberts EB, Bergan T (1978)
A medical education program strategy for community hospitals
Hosp Med Staff, 7 (1), 20-5
PubMed 10305370

Sjövall J, Magni L, Bergan T (1978)
Pharmacokinetics of bacampicillin compared with those of ampicillin, pivampicillin, and amoxycillin
Antimicrob Agents Chemother, 13 (1), 90-6
DOI 10.1128/AAC.13.1.90, PubMed 626496

BERGAN T, VERSLAND I (1978)
MINI-PIG AS A MODEL FOR PENETRATION OF PENICILLINS
Scand. J. Infect. Dis. (14), 135-142

Bergan T, Versland I (1978)
The mini-pig as a model for penetration of penicillins
Scand J Infect Dis Suppl (14), 135-42
PubMed 100872

Brodwall EK, Bergan T, Orjavik O (1977)
Kidney transport of cefazolin in normal and impaired renal function
J Antimicrob Chemother, 3 (6), 585-92
DOI 10.1093/jac/3.6.585, PubMed 599121

Bergan T, Brodwall EK, Orjavik O (1977)
Pharmacokinetics of cefazolin patients with normal and impaired renal function
J Antimicrob Chemother, 3 (5), 435-43
DOI 10.1093/jac/3.5.435, PubMed 903324

Bergan T, Vik-Mo H, Anstad U (1977)
Kinetics of a sulfadiazine-trimethoprim combination
Clin Pharmacol Ther, 22 (2), 211-24
DOI 10.1002/cpt1977222211, PubMed 884922

Bergan T (1977)
[New antimycotic drugs for systematic use]
Tidsskr Nor Laegeforen, 97 (16), 820-4
PubMed 69332

BERGAN T (1977)
COMPARATIVE PHARMACOKINETICS OF PENICILLINS ADMINISTERED INTRAVENOUSLY - THERAPEUTIC IMPLICATIONS
Med. Mal. Infect., 7 (2), 47-54
DOI 10.1016/S0399-077X(77)80166-2

Bergan T (1977)
Comparative pharmacokinetics of cefazolin, cephalothin, cephacetril, and cephapirine after intravenous administration
Chemotherapy, 23 (6), 389-404
DOI 10.1159/000222009, PubMed 923329

Bergan T (1976)
[Specific medicamentous blocking of penicillin allergy]
Tidsskr Nor Laegeforen, 96 (26), 1385-6
PubMed 968888

Bergan T, Lystad A (1976)
[Prevention of hepatitis transmission in dental practice]
Nor Tannlaegeforen Tid, 86 (8), 379-83
PubMed 1067588

Bergan T, Berdal BP, Holm V (1976)
Relative bioavailability of phenoxymethylpenicillin preparations in a cross-over study
Acta Pharmacol Toxicol (Copenh), 38 (4), 308-20
DOI 10.1111/j.1600-0773.1976.tb03125.x, PubMed 817566

Bratlid D, Bergan T (1976)
Displacement of albumin-bound antimicrobial agents by bilirubin
Pharmacology, 14 (5), 464-72
DOI 10.1159/000136629, PubMed 1031216

Bergan T, Brodwall EK (1976)
The Pharmacokinetic profile of co-trimoxazole
Scand J Infect Dis Suppl (8), 42-9
PubMed 1064911

BERGAN T, BRODWALL EK (1976)
PHARMACOKINETIC PROFILE OF CO-TRIMOXAZOLE
Scand. J. Infect. Dis. (8), 42-49

Bergan T, Hoiby N (1975)
Epidemiological markers for Pseudomonas aeruginosa. 6. Relationship between concomitant non-mucoid and mucoid strains from the respiratory tract in cystic fibrosis
Acta Pathol Microbiol Scand Suppl, 83 (6), 553-60
PubMed 812335

Jantzen E, Bryn K, Bergan T, Bovre K (1975)
Gas chromatography of bacterial whole cell methanolysates. VII. Fatty acid composition of Acinetobacter in relation to the taxonomy of Neisseriaceae
Acta Pathol Microbiol Scand Suppl, 83 (6), 569-80
PubMed 812336

Lund BM, Bergan T (1975)
[Use of skin tests with penicillin reagents in an infection ward]
Tidsskr Nor Laegeforen, 95 (31), 1784-6
PubMed 1188886

Berdal BP, Bergan T, Midtvedt T, Rollag H, Wetterhus S (1975)
[Penicillin V]
Tidsskr Nor Laegeforen, 95 (31), 1795-6
PubMed 810918

Bergan T, Niemelä T, Gyllenberg H (1975)
Epidemiological markers for Pseudomonas aeruginosa. 5. Subdivision by interative numerical analysis of isolates according to lysotypes
Acta Pathol Microbiol Scand B, 83 (3), 257-74
PubMed 808097

Bergan T, Sander J (1975)
[Urinary tract antiseptics]
Tidsskr Nor Laegeforen, 95 (6), 383-4
PubMed 1121691

Bergan T, Midtvedt T (1975)
Epidemiological markers for pseudomonas aeruginosa
Acta Pathol Microbiol Scand B, 83 (1), 1-9
DOI 10.1111/j.1699-0463.1975.tb00062.x, PubMed 805509

Andersen-Lund BM, Bergan T (1975)
[Intracutaneous testing in penicillin allergy]
Tidsskr Nor Laegeforen, 95 (3), 180-1
PubMed 1118840

Rollag H, Berdal BP, Bergan T, Degré M, Hovig B, Midtvedt T (1975)
[Letter: Microstix and N-labstix "Ames"--unsafe for proving bacteriuria]
Tidsskr Nor Laegeforen, 95 (3), 198
PubMed 1118846

Andersen Lund BM, Bergan T (1975)
Temporary skin reactions to penicillins during the acute stage of infectious mononucleosis
Scand J Infect Dis, 7 (1), 21-8
DOI 10.3109/inf.1975.7.issue-1.04, PubMed 1145129

JANTZEN E, BRYN K, BERGAN T, BOVRE K (1975)
GAS-CHROMATOGRAPHY OF BACTERIAL WHOLE CELL METHANOLYSATES .7. FATTY-ACID COMPOSITION OF ACINETOBACTER IN RELATION TO TAXONOMY OF NEISSERIACEAE
ACTA PATH MICRO IM B, 83 (6), 569-580

BERGAN T, MIDTVEDT T (1975)
EPIDEMIOLOGICAL MARKERS FOR PSEUDOMONAS-AERUGINOSA .4. CHANGE OF O-ANTIGEN AND PHAGE SENSITIVITY AFTER PHAGE INFECTION INVITRO AND INVIVO OF PSEUDOMONAS-AERUGINOSA
ACTA PATH MICRO IM B, B 83 (1), 1-9

BERGAN T, HOIBY N (1975)
EPIDEMIOLOGICAL MARKERS FOR PSEUDOMONAS-AERUGINOSA .6. RELATIONSHIP BETWEEN CONCOMITANT NON-MUCOID AND MUCOID STRAINS FROM RESPIRATORY-TRACT IN CYSTIC-FIBROSIS
ACTA PATH MICRO IM B, 83 (6), 553-560

Jantzen E, Bryn K, Bergan T, Bovre K (1974)
Gas chromatography of bacterial whole cell methanolysates; V. Fatty acid composition of Neisseriae and Moraxellae
Acta Pathol Microbiol Scand B Microbiol Immunol, 82 (6), 767-79
DOI 10.1111/j.1699-0463.1974.tb02374.x, PubMed 4218439

Jantzen E, Bergan T, Bovre K (1974)
Gas chromatography of bacterial whole cell methanolysates; VI. Fatty acid composition of strains within Micrococcaceae;
Acta Pathol Microbiol Scand B Microbiol Immunol, 82 (6), 785-98
PubMed 4533220

Bergan T (1974)
[Renal influence on kinetics and dosage of antibiotics]
Tidsskr Nor Laegeforen, 94 (27), 1644-9
PubMed 4417627

Rahe RH, Floistad I, Bergan T, Ringdal R, Gerhardt R, Gunderson EK, Arthur RJ (1974)
A model for life changes and illness research. Cross-cultural data from the Norwegian Navy
Arch Gen Psychiatry, 31 (2), 172-7
DOI 10.1001/archpsyc.1974.01760140030004, PubMed 4850226

Bergan T (1974)
[Tetra ammonium chains]
Tidsskr Nor Laegeforen, 94 (19), 1269-70
PubMed 4845301

Bergan T (1974)
[Glutaraldehyde]
Tidsskr Nor Laegeforen, 94 (18), 1203
PubMed 4209807

Bergan T (1974)
[Chlorhexidine]
Tidsskr Nor Laegeforen, 94 (16), 1082-3
PubMed 4841514

Bergan T (1974)
[Chlorine disinfection]
Tidsskr Nor Laegeforen, 94 (15), 1010
PubMed 4840766

Bergan T (1974)
[Phenol derivatives as general disinfectants]
Tidsskr Nor Laegeforen, 94 (14), 937-8
PubMed 4849385

RAHE RH, FLOISTAD I, BERGAN T, RINGDAL R, GERHARDT R, GUNDERSON EK, ARTHUR RJ (1974)
MODEL FOR LIFE CHANGES AND ILLNESS RESEARCH - CROSS-CULTURAL DATA FROM NORWEGIAN NAVY
Arch. Gen. Psychiatry, 31 (2), 172-177

Rieder J, Schwartz DE, Fernex M, Bergan T, Brodwall EK, Blumberg A, Cottier P, Scheitlin W (1974)
Pharmacokinetics of the antibacterial combination sulfamethoxazole plus trimethoprim in patients with normal or impaired kidney function
Antibiot Chemother (1971), 18, 148-98
DOI 10.1159/000395184, PubMed 4463825

JANTZEN E, BRYN K, BERGAN T, BOVRE K (1974)
GAS-CHROMATOGRAPHY OF BACTERIAL WHOLE CELL METHANOLYSATES .5. FATTY-ACID COMPOSITION OF NEISSERIAE AND MORAXELLAE
ACTA PATH MICRO IM B, B 82 (6), 767-779

Bergan T, Oydvin B (1974)
Cross-over study of penicillin pharmacokinetics after intravenous infusions
Chemotherapy, 20 (5), 263-79
DOI 10.1159/000221816, PubMed 4412673

JANTZEN E, BERGAN T, BOVRE K (1974)
GAS-CHROMATOGRAPHY OF BACTERIAL WHOLE CELL METHANOLYSATES .6. FATTY-ACID COMPOSITION OF STRAINS WITHIN MICROCOCCACEAE
ACTA PATH MICRO IM B, B 82 (6), 785-798

Bergan T (1973)
[Sulfonamides]
Tidsskr Nor Laegeforen, 93 (30), 2252-5
PubMed 4766397

Bergan T (1973)
[Antibiotics, 5. Gentamycin]
Ugeskr Laeger, 135 (44), 2399-401
PubMed 4774025

Bergan T (1973)
[Skin disinfection]
Tidsskr Nor Laegeforen, 93 (4), 255-6
PubMed 4691030

Bergan T (1973)
Epidemiological markers for Pseudomonas aeruginosa. 3. Comparison of bacteriophage typing, serogrouping, and pyocine typing on a heterogeneous clinical material
Acta Pathol Microbiol Scand B Microbiol Immunol, 81 (1), 91-101
PubMed 4199592

Bergan T (1973)
Epidemiological markers for Pseudomonas aeruginosa. 1. Serogrouping, pyocine typing--and their interrelations
Acta Pathol Microbiol Scand B Microbiol Immunol, 81 (1), 70-80
PubMed 4199590

Bergan T (1973)
Epidemiological markers for Pseudomonas aeruginosa. 2. Relationship between bacteriophage susceptibility and serogroup or pyocine type
Acta Pathol Microbiol Scand B Microbiol Immunol, 81 (1), 81-90
PubMed 4199591

Bergan T (1973)
[Antibacterial agents. 5. Gentamycin]
Tidsskr Nor Laegeforen, 93 (1), 34-6
PubMed 4632374

Kozaczek W, Bergan T, Lachowicz T, Szczepański K (1973)
[Detection of sources and routes of infection with Pseudomonas aeruginosa in a urologic department]
Przegl Epidemiol, 27 (1), 37-44
PubMed 4196323

Bergan T, Oydvin B, Lunde I (1973)
Biological availability and in vitro release from oral oxytetracycline and tetracycline preparations
Acta Pharmacol Toxicol (Copenh), 33 (2), 138-56
DOI 10.1111/j.1600-0773.1973.tb01517.x, PubMed 4585587

BERGAN T (1973)
EPIDEMIOLOGICAL MARKERS FOR PSEUDOMONAS-AERUGINOSA .2. RELATIONSHIP BETWEEN BACTERIOPHAGE SUSCEPTIBILITY AND SEROGROUP OR PYOCINE TYPE
ACTA PATH MICRO IM B, B 81 (1), 81-90

BERGAN T (1973)
EPIDEMIOLOGICAL MARKERS FOR PSEUDOMONAS-AERUGINOSA .3. COMPARISON OF BACTERIOPHAGE TYPING, SEROGROUPING, AND PYOCINE TYPING ON A HETEROGENEOUS CLINICAL MATERIAL
ACTA PATH MICRO IM B, B 81 (1), 91-101

Bergan T, Brodwall EK, Westlie L, Oyri A (1973)
Renal excretion of gentamicin and effect of probenecid
Acta Pathol Microbiol Scand B Microbiol Immunol, Suppl 241:95-8
PubMed 4521611

BERGAN T, BRODWALL EK, WESTLIE L, OYRI A (1973)
RENAL EXCRETION OF GENTAMICIN AND EFFECT OF PROBENECID
ACTA PATH MICRO IM B (241), 95-98

BERGAN T (1973)
EPIDEMIOLOGICAL MARKERS FOR PSEUDOMONAS-AERUGINOSA .1. SEROGROUPING, PYOCINE TYPING - AND THEIR INTERRELATIONS
ACTA PATH MICRO IM B, B 81 (1), 70-80

Bergan T (1972)
[Chemical disinfection of dirty clothes wash]
Tidsskr Nor Laegeforen, 92 (35), 2444-6
PubMed 4657024

Bergan T (1972)
[Sulfalen (Kelfizin)]
Tidsskr Nor Laegeforen, 92 (34), 2353-4
PubMed 4650314

Bergan T, Brodwall EK (1972)
Human pharmacokinetics of a sulfamethoxazole-trimethoprim combination
Acta Med Scand, 192 (6), 483-92
DOI 10.1111/j.0954-6820.1972.tb04852.x, PubMed 4640694

Bergan T (1972)
[Iodine]
Tidsskr Nor Laegeforen, 92 (33), 2278-9
PubMed 4649635

Bergan T, Lystad A (1972)
[Practical use of chemical disinfectants in health institutions]
Tidsskr Nor Laegeforen, 92 (28), 1847-52
PubMed 4652739

Bergan T (1972)
[Beware of neomycin in peritoneal dialysis]
Tidsskr Nor Laegeforen, 92 (12), 882-3
PubMed 5028912

Bergan T (1972)
[Determination of antimicrobials in serum and tissue fluids]
Tidsskr Nor Laegeforen, 92 (8), 575-8
PubMed 5021898

Bergan T (1972)
[Pivampicillin (Pondocillin)--a new ampicillin alternative]
Tidsskr Nor Laegeforen, 92 (7), 513-4
PubMed 5035501

Bergan T, Westlie L, Brodwall EK (1972)
Influence of probenecid on gentamycin pharmacokinetics
Acta Med Scand, 191 (3), 221-4
PubMed 5033712

Bergan T (1972)
[Clinical evaluation of sulfamethoxazole-trimethoprim]
Tidsskr Nor Laegeforen, 92 (4), 265-9
PubMed 5016490

Bergan T (1972)
[Pharmacodynamics and bacteriology in sulfamethoxazole-trimetoprim combination therapy]
Tidsskr Nor Laegeforen, 92 (4), 274-7
PubMed 5016492

Bergan T (1972)
A transformed Yule correlation coefficient employed in numerical grouping procedures on bacteriophage lytic spectra
Acta Pathol Microbiol Scand B Microbiol Immunol, 80 (1), 89-100
DOI 10.1111/j.1699-0463.1972.tb00133.x, PubMed 4623082

Bergan T, Lystad A (1972)
Evaluation of phenolics by a quantitative technique
Acta Pathol Microbiol Scand B Microbiol Immunol, 80 (1), 71-8
DOI 10.1111/j.1699-0463.1972.tb00131.x, PubMed 4553304

Bergan T, Oydvin B (1972)
Microbiological assay of josamycin
Acta Pathol Microbiol Scand B Microbiol Immunol, 80 (1), 101-6
DOI 10.1111/j.1699-0463.1972.tb00134.x, PubMed 4401673

Bergan T (1972)
Bacteriophage typing and serogrouping of Pseudomonas aeruginosa from animals
Acta Pathol Microbiol Scand B Microbiol Immunol, 80 (3), 351-61
DOI 10.1111/j.1699-0463.1972.tb00046.x, PubMed 4626005

Bergan T (1972)
A new bacteriophage typing set for Pseudomonas aeruginosa. 1. Selection procedure
Acta Pathol Microbiol Scand B Microbiol Immunol, 80 (2), 177-88
DOI 10.1111/j.1699-0463.1972.tb00148.x, PubMed 4624530

Bergan T (1972)
Comparison of numerical procedures for grouping pseudomonas bacteriophages according to lytic spectra
Acta Pathol Microbiol Scand B Microbiol Immunol, 80 (1), 55-70
DOI 10.1111/j.1699-0463.1972.tb00130.x, PubMed 4623080

Bergan T, Lystad A (1972)
Evaluation of disinfectant inactivators
Acta Pathol Microbiol Scand B Microbiol Immunol, 80 (4), 507-10
DOI 10.1111/j.1699-0463.1972.tb00173.x, PubMed 4566180

Bergan T, Brodwall EK (1972)
Kidney transport in man of sulfamethoxazole and trimethoprim
Chemotherapy, 17 (5), 320-33
DOI 10.1159/000220864, PubMed 4669555

Bergan T (1972)
A new bacteriophage typing set for Pseudomonas aeruginosa. 2. Characterization and comparisons of new and previous typing sets
Acta Pathol Microbiol Scand B Microbiol Immunol, 80 (2), 189-201
DOI 10.1111/j.1699-0463.1972.tb00149.x, PubMed 4624531

Bergan T, Lystad A (1972)
Evaluation of non-phenolics by a quantitative technique
Acta Pathol Microbiol Scand B Microbiol Immunol, 80 (1), 79-88
DOI 10.1111/j.1699-0463.1972.tb00132.x, PubMed 4623081

Bergan T, Tolås P, Oydvin B (1972)
Influence of food and hepatobiliary disease on the excretion of josamycin
Pharmacology, 8 (4), 336-43
DOI 10.1159/000136351, PubMed 4572010

Bergan T, Lystad A (1972)
Reproducibility in bacteriophage sensitivity pattern of Pseudomonas aeruginosa
Acta Pathol Microbiol Scand B Microbiol Immunol, 80 (3), 345-50
DOI 10.1111/j.1699-0463.1972.tb00045.x, PubMed 4626004

Kocur M, Bergan T, Mortensen N (1971)
DNA base composition of Gram-positive cocci
J Gen Microbiol, 69 (2), 167-83
DOI 10.1099/00221287-69-2-167, PubMed 5146835

Bergan T, Lystad A (1971)
Antitubercular action of disinfectants
J Appl Bacteriol, 34 (4), 751-6
DOI 10.1111/j.1365-2672.1971.tb01011.x, PubMed 5004246

Bergan T, Lystad A (1971)
Disinfectant evaluation by a capacity use-dilution test
J Appl Bacteriol, 34 (4), 741-50
DOI 10.1111/j.1365-2672.1971.tb01010.x, PubMed 4947441

Bergan T (1971)
[Tetracycline-induced tooth injuries in children]
Tidsskr Nor Laegeforen, 91 (15), 1160
PubMed 5562168

Bergan T (1971)
Influence of cultural milieu on the replication of pseudomonas bacteriophages
Acta Pathol Microbiol Scand B Microbiol Immunol, 79 (6), 841-9
DOI 10.1111/j.1699-0463.1971.tb00120.x, PubMed 5003330

Bergan T, Brodwall EK, Oyri A (1971)
Renal excretion of gentamycin in chronic pyelonephritis
Acta Med Scand, 189 (1-2), 1-5
DOI 10.1111/j.0954-6820.1971.tb04332.x, PubMed 5121528

Bergan T, Midtvedt T, Erikssen J (1970)
Human pharmacokinetics of cephalexin
Pharmacology, 4 (5), 264-72
DOI 10.1159/000136146, PubMed 5490473

Erikssen J, Midtvedt T, Bergan T (1970)
Treatment of urinary tract infections with cephalexin
Scand J Infect Dis, 2 (1), 53-8
DOI 10.3109/inf.1970.2.issue-1.09, PubMed 5520522

Bergan T, Bovre K, Hovig B (1970)
Reisolation of Micrococcus mucilaginosus Migula 1900
Acta Pathol Microbiol Scand B Microbiol Immunol, 78 (1), 85-97
DOI 10.1111/j.1699-0463.1970.tb04272.x, PubMed 5268186

Bovre K, Bergan T, Froholm LO (1970)
Electron microscopical and serological characteristics associated with colony type in Moraxella nonliquefaciens
Acta Pathol Microbiol Scand B Microbiol Immunol, 78 (6), 765-79
DOI 10.1111/j.1699-0463.1970.tb04368.x, PubMed 5278895

Bergan T (1969)
[Treatment of Pseudomonas aeruginosa infections]
Tidsskr Nor Laegeforen, 89 (19), 1495-8
PubMed 4986547

Bergan T (1969)
[Pseudomonas aeruginosa. A pathogenic microbe of current importance]
Tidsskr Nor Laegeforen, 89 (12), 1014-6
PubMed 4979183

Bergan T (1969)
[Carbenicillin--a new penicillin derivative. In vitro effect on Pseudomonas aeruginosa]
Tidsskr Nor Laegeforen, 89 (11), 814-5
PubMed 4978393

Bergan T (1969)
[Resistance in vitro of Psudomonas aeruginosa to gentamicin compared with colistin and polymyxin B]
Nord Med, 81 (3), 73-5
PubMed 4304204

Bergan T, Hovig B (1969)
Hyaluronic acid capsule in a Streptococcus faecalis var. zymogenes. A comparison with related mucoid strains
Acta Pathol Microbiol Scand, 75 (1), 97-103
PubMed 4978702

Bergan T (1968)
[Pseudomonas aeruginosa - typing methods and hospital infections]
Nord Med, 79 (16), 505-8
PubMed 4968666

Bergan T (1968)
A contrivance for bacteriocine typing
Acta Pathol Microbiol Scand, 72 (3), 396-400
DOI 10.1111/j.1699-0463.1968.tb00452.x, PubMed 4967984

Bergan T, Hovig B (1968)
A new species, Sphaerophorus intermedius, isolated from empyema
Acta Pathol Microbiol Scand, 74 (3), 421-30
DOI 10.1111/j.1699-0463.1968.tb03496.x, PubMed 4889145

Bergan T (1968)
Typing of Pseudomonas aeruginosa by pyocine production
Acta Pathol Microbiol Scand, 72 (3), 401-11
DOI 10.1111/j.1699-0463.1968.tb00453.x, PubMed 4967985

BERGAN T (1964)
[THE PANCREATIC-GASTRIC SYNDROME (STROM-ZOLLINGER-ELLISON SYNDROME)]
Tidsskr Nor Laegeforen, 84, 1468-72
PubMed 14241421

Review articles

Bergan T (1995)
Quinolones in the elderly
Drugs, 49 Suppl 2, 112-4
DOI 10.2165/00003495-199500492-00017, PubMed 8549278

Bergan T (1990)
Pharmacokinetic parameters and characteristics relevant to antimicrobial surgical prophylaxis
Scand J Infect Dis Suppl, 70, 31-5
PubMed 2287901

Thorsteinsson SB, Rahm V, Bergan T (1989)
Tolerance of intravenous ciprofloxacin
Scand J Infect Dis Suppl, 60, 116-9
PubMed 2667104

Bergan T, Engeset A, Olszewski W (1987)
Does serum protein binding inhibit tissue penetration of antibiotics?
Rev Infect Dis, 9 (4), 713-8
DOI 10.1093/clinids/9.4.713, PubMed 3326121

Bergan T, Ortengren B, Westerlund D (1986)
Clinical pharmacokinetics of co-trimazine
Clin Pharmacokinet, 11 (5), 372-86
DOI 10.2165/00003088-198611050-00003, PubMed 3536256

Bergan T (1986)
Pharmacokinetic differentiation and consequences for normal microflora
Scand J Infect Dis Suppl, 49, 91-9
PubMed 3547629

Bergan T (1986)
Requirements for pharmacokinetic evaluation of antibiotics in phase I studies
Rev Infect Dis, 8 Suppl 3, S319-24
DOI 10.1093/clinids/8.supplement_3.s319, PubMed 3749695

Bergan T (1985)
[Pharmacokinetics and tissue penetration of ceftriaxone]
Rev Med Interne, 6 (2), 163-77
DOI 10.1016/s0248-8663(85)80061-8, PubMed 3890053

BERGAN T (1984)
CLASSIFICATION OF ENTEROBACTERIACEAE
Methods Microbiol., 14, 1-41
DOI 10.1016/S0580-9517(08)70446-X

Bergan T (1984)
Pathogenicity of anaerobic bacteria
Scand J Gastroenterol Suppl, 91, 1-11
PubMed 6377469

Bergan T (1983)
Anaerobic bacteria as cause of infections in female genital organs
Scand J Gastroenterol Suppl, 85, 37-47
PubMed 6353553

Fuglesang J, Bergan T (1982)
Chloramphenicol and thiamphenicol
Antibiot Chemother (1971), 31, 1-21
DOI 10.1159/000400129, PubMed 7036847

Bergan T, Fuglesang J (1982)
Polymyxin antibiotics: chemical and pharmacokinetic properties
Antibiot Chemother (1971), 31, 119-44
PubMed 6277240

Bergan T (1981)
Pathogenetic factors of Pseudomonas aeruginosa
Scand J Infect Dis Suppl, 29, 7-12
PubMed 6797059

Bergan T (1981)
Overview of acylureidopenicillin pharmacokinetics
Scand J Infect Dis Suppl, 29, 33-48
PubMed 7031864

Bergan T (1978)
Penicillins
Antibiot Chemother (1971), 25, 1-122
DOI 10.1159/000401058, PubMed 352250

Bergan T (1971)
Survey of numerical techniques for grouping
Bacteriol Rev, 35 (4), 379-89
DOI 10.1128/br.35.4.379-389.1971, PubMed 4945724